Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
68.273,97
0,81%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Encysive Pharmaceuticals (MM) (ENCY) Encysive Pharmaceuticals (MM) (ENCY) Notizie

ENCY

Encysive Pharmaceuticals (MM) (ENCY)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ENCY
DataOraFonteTitoloSimboloCompagnia
10/06/200815:48Edgar (US Regulatory)Encysive Pharmaceuticals Inc- (25-NSE)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
10/06/200813:00Business WirePfizer Completes Acquisition of Encysive Pharmaceuticals Inc.NASDAQ:ENCYEncysive Pharmaceuticals (MM)
12/05/200823:15Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
12/05/200820:24Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Schedule 13GNASDAQ:ENCYEncysive Pharmaceuticals (MM)
30/04/200823:31Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
16/04/200823:31Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
16/04/200822:50Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
15/04/200823:30Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
15/04/200822:27Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
11/04/200823:21Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
11/04/200821:58Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
08/04/200814:10Business WirePfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive PharmaceuticalsNASDAQ:ENCYEncysive Pharmaceuticals (MM)
08/04/200800:28Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
08/04/200800:26Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (3/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
07/04/200823:02Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
07/04/200820:04Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
03/04/200822:46PR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Respiratory Pulmonary Index and the HealthShares(TM) CompNASDAQ:ENCYEncysive Pharmaceuticals (MM)
27/03/200822:05Business WirePfizer Obtains Clearance from Federal Cartel Office of Germany for Acquisition of All Outstanding Shares of Encysive PharmaceutiNASDAQ:ENCYEncysive Pharmaceuticals (MM)
27/03/200813:00Business WirePfizer Clears U.S. Antitrust Review for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc.NASDAQ:ENCYEncysive Pharmaceuticals (MM)
27/03/200811:01Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Annual Report (10-K/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
17/03/200822:17Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
04/03/200823:01Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
04/03/200822:58Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Tender offer statement by Third Party (SC TO-T)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
04/03/200822:56Business WirePfizer Announces Commencement of Tender Offer for All Outstanding Shares of Encysive Pharmaceuticals Inc.NASDAQ:ENCYEncysive Pharmaceuticals (MM)
21/02/200815:48PR Newswire (US)BeaconEquity.com Issues TraderNotes on MTTG, ENCY, RIMM, DRYS, SPWRNASDAQ:ENCYEncysive Pharmaceuticals (MM)
20/02/200815:14Business WirePfizer to Acquire Encysive PharmaceuticalsNASDAQ:ENCYEncysive Pharmaceuticals (MM)
14/02/200818:08Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Schedule 13G (SC 13G/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
15/01/200823:03Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Current report filing (8-K/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
24/09/200723:14Edgar (US Regulatory)Encysive Pharmaceuticals Inc (Other) (8-K)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
06/09/200712:02Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Current report filingNASDAQ:ENCYEncysive Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ENCY

La tua Cronologia

LSE
HR1O
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network